XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill and Intangible Assets
6 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

3. Goodwill and Intangible Assets

 

Goodwill

 

Activity related to goodwill consisted of the following (in thousands):

 

 

 

Six Months

 

 

 

 

 

Ended

 

Year Ended

 

 

 

December 31,

 

June 30,

 

 

 

2012

 

2012

 

Balance at the beginning of the period

 

$

59,215

 

$

54,474

 

Addition related to acquisition

 

77

 

 

Currency translation and other adjustments

 

97

 

 

Adjustments related to prior year acquisition (1)

 

 

4,741

 

Balance at the end of the period

 

$

59,389

 

$

59,215

 

 

(1)  Primarily represents liabilities related to the TomoTherapy acquisition.

 

Intangible Assets

 

The Company’s intangible assets associated with completed acquisitions at December 31, 2012 and June 30, 2012 are as follows (in thousands):

 

 

 

 

 

December 31, 2012

 

June 30, 2012

 

 

 

 

 

Gross

 

 

 

 

 

Gross

 

 

 

 

 

 

 

 

 

Carrying

 

Accumulated

 

Net

 

Carrying

 

Accumulated

 

Net

 

 

 

Useful Lives

 

Amount

 

Amortization

 

Amount

 

Amount

 

Amortization

 

Amount

 

 

 

(in years)

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

5 - 6

 

$

48,556

 

$

(13,107

)

$

35,449

 

$

43,455

 

$

(9,161

)

$

34,294

 

Backlog

 

1.25

 

10,500

 

(10,500

)

 

10,500

 

(8,867

)

1,633

 

Distributor license

 

1.5 - 2.5

 

2,070

 

(1,202

)

868

 

1,860

 

(768

)

1,092

 

In-process research and development (CPAC)

 

Indefinite

 

 

 

 

12,800

 

 

12,800

 

 

 

 

 

$

61,126

 

$

(24,809

)

$

36,317

 

$

68,615

 

$

(18,796

)

$

49,819

 

 

Prior to the deconsolidation of CPAC on December 21, 2012 (see Note 9), the Company had noted certain impairment triggers based on results of research and development work carried out by CPAC. As a result, based on projected future usage of the in-process research and development (“IPR&D”) technology by CPAC, an impairment charge of $12.2 million was recorded during the three months ended September 30, 2012.  The Company did not identify any impairment triggers on goodwill or any of its other definite-lived intangible and long-lived assets.

 

Amortization expense related to intangible assets for the three and six months ended December 31, 2012 was $2.2 million and $6.0 million, respectively. Amortization expense related to intangible assets for the three and six months ended December 31, 2011 was $4.1 million and $8.2 million, respectively.

 

The estimated future amortization expense of purchased intangible assets as of December 31, 2012 is as follows (in thousands):

 

Year Ending June 30, 

 

Amount

 

2013 (remaining 6 months)

 

$

4,412

 

2014

 

8,388

 

2015

 

7,953

 

2016

 

7,953

 

2017

 

7,568

 

Thereafter

 

43

 

 

 

$

36,317